Deleterious effect of T‐ and B‐cell panel reactive antibodies and donor‐specific B‐cell crossmatches on cadaveric renal allograft survival

Dharmendra P. S. Sengar,Roger A. Couture,Robert C. Bell,Andrew I. Lazarovlts,Shiv L. Jindal

DOI: https://doi.org/10.1111/j.1399-0012.1990.tb00215.x

1990-04-01

Clinical Transplantation

Abstract:A total of 222 cadaveric renal allografts (Tx) were analyzed to evaluate the effect of non‐current and current T‐cell as well as B‐cell panel reactive antibodies (PRA) on Tx survival. In addition, the effect of donor‐specific B‐cell crossmatches (XMs) on Tx survival in association with T‐ and B‐cell PRA was also evaluated. The majority (80%) of patients received cyclosporine (CsA). Our study revealed that the presence of non‐current or current T‐cell PRA ≥ 10% and/or B‐cell PRA ≥ 25% had a deleterious effect on Tx outcome. Similarly, patients with < 10% T‐ and ≥ 25% B‐cell PRA also had lower Tx survival than those with < 10% T‐ and < 25% B‐cell PRA. Positive B‐cell XMs were associated with lower (but not significant) Tx survival. In the patients with negative B‐cell XMs, the presence of ≥; 10% T‐cell and/or ≥ 25% B‐cell PRA was significantly associated with lower Tx survival. Overall results suggest that perhaps certain other factors (or antibodies) non‐cytotoxic to T and B cells, but detrimental to Tx, may be concomitantly present in these sensitized patients. Furthermore, patients with non‐current T‐cell PRA ≥ 25% (median 45%) after losing their T‐cell PRA prior to transplantation continued to have poor Tx survival. The present study suggests that B‐cell PRA alone or in association with T‐cell PRA and B‐cell XMs may serve as a good predictor of Tx outcome.

surgery,transplantation